A review of more than 60 studies has concluded that “there is no long-term evidence that mental health concerns are decreased or alleviated after ‘gender-affirming therapy,’” according to a national group of physicians.
The American College of Pediatricians (ACPeds) on Wednesday issued its position statement opposing the use of so-called “gender-affirming” medications, such as puberty blockers and cross-sex hormones, social transition, and surgery for youth who have a gender identity not congruent with their sex.
“We urge medical professionals and parents to affirm the truth about childhood gender dysphoria in the presence of harmful thoughts and address the underlying mental illness, adverse events, and family dysfunction,” said Dr. Jane Anderson, lead author and vice president of ACPeds, in a statement.
The group found there is substantial evidence that transgender youth suffer from high rates of mental health problems.
“From this review of the literature, there is strong evidence that children and adolescents who identify as transgender have experienced significant psychological trauma leading to their gender dysphoria,” ACPeds concluded.
ACPeds position outlines the studies that have led a number of European countries, including Finland, Norway, and Sweden, to reverse their positions and reject gender-reassignment treatments in young people.
Hellbound and Down 